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Abstract. In this paper, we propose a rule-based formalization of eligibility criteria for
clinical trials. The rule-based formalization is implemented by using the logic programming
language Prolog. Compared with existing formalizations such as pattern-based and script-
based languages, the rule-based formalization has the advantages of being declarative, ex-
pressive, reusable and easy to maintain. Our rule-based formalisation is based on a general
framework for eligibility criteria containting three types of knowledge: (1) trial-specific
knowledge, (2) domain-specific knowledge and (3) common knowledge. This framework
enables the reuse of several parts of the formalisation of eligibility criteria. We have im-
plemented the proposed rule-based formalization in SemanticCT, a semantically-enabled
system for clinical trials, showing the feasibility of using our rule-based formalization of
eligibility criteria for supporting patient recruitment in clinical trial systems.
1 Introduction
Clinical trials have played important roles in medical research and drug development, because
they provide sets of tests which generate safety and efficacy data for health interventions. How-
ever, the work in clinical trials have been considered to be laborious, sometimes, exhausting,
because many procedures in clinical trials, such as patient recruitment (i.e., finding eligible pa-
tients for a trial) and trial finding (i.e., finding suitable trials for a patient), usually require
manually processes. The goal of the formalizations of eligibility criteria is to provide faster iden-
tification of patients for trials and automatic identification of clinical trials for patients. That
requires the implementation of the advanced reasoning services for matching patient data with
formalized eligibility criteria.
There have been several attempts to the formulizations of eligibility criteria for clinical tri-
als, which include pattern-based formalization, semantic-annotation–based formalization, and
script-based formalization [1]. Compared with existing formalizations, a rule-based formalization
is expected to be efficient and effective, because of their declarative nature, their high expres-
siveness, their reusability and easy maintenance. We have implemented the proposed rule-based
formulization in SemanticCT, a semantically-enabled system for clinical trials [2]1. SemanticCT
provides semantic integration of various data in clinical trials. The system is designed to be a
semantically-enabled system for decision support in various settings of clinical trials. In this pa-
per we will show that the rule-based formalization of eligibility criteria is an efficient approach
to identifying eligible patients for clinical trials.
This paper is organized as follows: After a brief motivation for rules as a formalisation lan-
guage and for Prolog as a corresponding implementation language (Section 2), we present a small
framework that captures three different types of knowledge that play a role in eligibility criteria
(Section 3). Section 4 then discusses the formalization of these different knowledge in terms of
1 http://wasp.cs.vu.nl/sct
rules. Section 5 discusses our implementation of this formalisation, and presents some experi-
ments that show the feasibility of our approach. Section 6 discusses related work, concludes, and
discusses the future work.
2 Motivation for Rules and Prolog
2.1 Rules
A rule-based formalization is expected to be an efficient and effective formalism to support
automatic patient recruitment and trial feasibility testing, because of the following features:
Declarative. A rule-based formalization is a declarative language that expresses the logic
of a computation without the need of exactly describing its control flow. That is significantly
different from traditional programming languages, like Java, which use a procedural approach for
the specification of control flow in the computation. A declarative formalization is more suitable
for knowledge representation and reasoning because it needs no carefully design its computation
(or reasoning) procedure. Thus, a rule-based formalization of eligibility criteria would provide
a more convenient and efficient way for the automatic patient recruitments in clinical trials,
compared with other procedural approaches, like the script-based formalization, which relies
procedural scripts, and the pattern-based approach, which is based on SPARQL queries with
regular expressions.
Easy Maintenance. Rule-based formalization provides an approach in which specified knowl-
edge is easy to be understood for human users, because they are very close to human knowledge.
It would not be too hard for human users to check the correctness of the specification of eligibility
criteria if they are formalized as a set of rules. Furthermore, changing or revising a single rule
would not make an effect on other part of the formalization significantly, because the meaning of
the specification is usually represented in the specific rule. Thus, it is much easier for maintenance
of knowledge, compared with procedural/scripting approaches of the formalization of eligibility
criteria.
Reusability. In a rule-based formalization, a single rule (or a set of rules) is usually considered
to be independent from other part of knowledge. Thus, it is much more convenient to re-use
some rules of a formalized clinical trial for formalization of other trials. Furthermore, some rules
which specify common knowledge, such as rules for temporal reasoning, and domain knowledge,
and those that specify knowledge of diseases, can be designed to be a common library, which can
be re-used for the formalization of other trials.
Expressiveness. Automatic patient recruitment usually involves comprehensive scenarios of
deliberation and decision-making procedures. To facilitate those capabilities, it may require so-
phisticated data processing in workflows. An expressive rule-based language can support various
functionalities of data processing. Thus, it provides the possibility to build workflows for various
scenarios of medical applications.
2.2 Rule-based Language Prolog
There exist various rule languages which can be used for the formalization of eligibility criteria. In
the researches of artificial intelligence, logic programming languages, like Prolog, are well known
and popular rule-based languages. Several rule-based languages, like SWRL2 and RIF3, have
been proposed for the semantics-enable rule-based language. In biomedical domain, the Arden
syntax 4 has been developed to formalize rule-like medical knowledge. However, compared with
2 http://www.w3.org/Submission/SWRL/
3 http://www.w3.org/TR/rif-overview/
4 http://www.hl7.org/special/Committees/arden/index.cfm
logic programming language Prolog, both SWRL, RIF and the Arden syntax have very limited
functionalities for data processing.
In this paper, we will propose a rule-based formalization, which is based on the logic pro-
gramming language Prolog. Prolog is a general purpose logic programming language associated
with artificial intelligence, in particular, for knowledge representation and reasoning.
In Prolog, program logic is expressed in terms of relations. More exactly, those relations are
formalized as a set of the predicates, like those in the first order logic. A computation is initiated
by running a query over these relations.
In Prolog, the relations are represented as an atom which consists of a predicate with several
terms as its parameters, like this: age between(PatientData, AgeMin, AgeMax).
A rule in Prolog has the following form
Head :- Body.
Where Head is an atomic formula, and Body is a list of atomic formulas which are separated
with commas and ends with a dot. For example,
triple_negative(Patient):-
er_negative(Patient), pr_negative(Patient), her2_negative(Patient).
Which means that a patient of breast cancer is triple negative if it is ER negative, PR negative,
and HER2 negative.
More exactly, our rule-based formalization is developed based on the SWI-Prolog5. The rea-
sons why we select SWI-Prolog as the basic language for the rule-based formalization, because
of the following features of it’s powerful libraries and its semantic web support SWI-Prolog [3].
3 Framework
In this section we will first sketch the structure of typical eligibility criteria, and based on this we
will describe a simpleframework that captures three different types of knowledge that typically
occur in such eligibility criteria
3.1 Eligibility Criteria
Eligibility criteria consist of inclusion criteria, which state a set of conditions that must be met,
and exclusion criteria, which state a set of conditions that must not be met, in order to participate
in a clinical trial.
Take the example of the trial NCT00002720, the eligibility criteria are:
DISEASE CHARACTERISTICS:
- Histologically proven stage I, invasive breast cancer
- Hormone receptor status:
- Estrogen receptor positive
- Progesterone receptor positive or negative
PATIENT CHARACTERISTICS:
Age: 65 to 80,
Sex: Female
Menopausal status: Postmenopausal
Other: - No serious disease that would preclude surgery
- No other prior or concurrent malignancy except basal cell
carcinoma or carcinoma in situ of the cervix
5 http://www.swi-prolog.org/
Those inclusion criteria (such as ’invasive breast cancer’ ) and exclusion criteria (such as ’No
serious disease that would preclude surgery’) are trial specific. However, in order to check whether
or not a required item (i.e., a criterion) has been met by a patient record, we need some domain
knowledge to interpret the requirement and make it directly checkable from patient data. For
example, ’invasive breast cancer’ can be defined as either ’invasive ductal carcinoma’ or ’invasive
lobular carcinoma’ in the diagnosis. Furthermore, we need some knowledge, such as temporal
reasoning knowledge, to deal with temporal aspects of criteria, and service interface knowledge,
to get the corresponding patient data from the EHR or CMR servers.
3.2 Different Knowledge Levels
We can formalize the knowledge rules of the specification of eligibility criteria of clinical trials
with respect to the following different re-usable knowledge types:
Trial-specific Knowledge. Trial-specific knowledge are those rules which specify the concrete
details of the eligibility criteria of a specific clinical trial. Those criteria are different from one
trial to another. This is the formalisation of which specific inclusion criteria and exclusion criteria
are required for a particular clinical trial. The formalisation of the criteria themselves are part
of the other levels of knowledge.
Domain-specific Knowledge. Those trial-specific rules above may involve some knowledge
which is domain specific, but that domain knowledge is in principle trial independent. Sch domain
specific, but trial independent knowledge can be formalised in re-usable libraries. For example,
for clinical trials of breast cancer, we formalize the knowledge of breast cancer in the knowledge
bases of breast cancer, a domain-specific library of rules. An example ot this type of knowledge
is a patient of breast cancer is triple nagative if the patient has estrogon receptor negative,
progesterone receptor negative and protein HER2 negative status.
Common Knowledge. The specification of the eligibility criteria may involve some knowledge
which is domain independent, like for example knowledge about temporal reasoning and the
knowledge for manipulating semantic data and interacting with data servers, e.g. how to obtain
the data from SPARQL endpoints. We formalize those knowledge in several rule libraries, which
can again be reused across different applications.
4 Formalization
4.1 Formalization of Trial-specific knowledge
For the specification of eligibility criteria, we usually formalize their inclusion criteria and exclu-
sion criteria respectively.
Given a patient ID, we suppose that we can obtain its patient data through the common
knowledge of the interface with SPARQL endpoints and its internal data storage. Thus, in order
to check if a patient meets an inclusion criterion, we can check if its patient data meet the
criterion. Furthermore, we would not expect to check all the criteria with respect to the patient
data, because some of those required data may be missing in the patient data. We introduce
a special predicate getNotYetCheckedItems to collect those criteria which have not yet been
formalized for the trial.
The inclusion criteria in the trial NCT00002720 above can be formalized in the following:
meetInclusionCriteria(_PatientID, PatientData, CT, NotYetCheckedItems):-
CT = ’nct00002720’,
breast_cancer_stage(PatientData, ’1’),
invasive_breast_cancer(PatientData),
er_positive(PatientData),
known_pr_status(PatientData),
age_between(PatientData, 65, 80),
postmenopausal(PatientData),
getNotYetCheckedItems(CT, NotYetCheckedItems).
There are no exclusion criteria for the trial ’NCT00002720’6. Thus, we formalize it as follow:
meetExclusionCriteria(_PatientID, _PatientData, CT):- CT = ’nct00002720’, false.
If there is an exclusion criteria, like this: ’no currently pregnant’, we can formalize the exclu-
sion criteria as follows:
meetExclusionCriteria(_PatientID, PatientData, CT):-
CT=’nct00002720’,
currentlyPregnant(PatientData).
We formalize the criteria which have not been checked in a rule like this:
getNotYetCheckedItems(CT, NotYetCheckedItems):-
CT=’nct00002720’,
Item1 = ’No serious disease that would preclude surgery’,
Item2 = ’No other prior or concurrent malignancy except
basal cell carcinoma or carcinoma in situ of the cervix’,
NotYetCheckedItems = [Item1, Item2].
4.2 Formalization of Domain-specific Knowledge
We consider patient data as a set of property-value pairs. A general format of patient data, called
the PrologCMR format, is designed to be a list of property-value pairs, like this:
[gender:Gender,
birthyear:BirthYear,
menopause:Menopause,
currentlyPregnant:Pregnant,
currentlyNursing:Nursing,
diagnosis:Diagnosis,
diagnosisyear:DiagnosisYear,
her2:HER2,
er:ER,
pr:PR,
stage:Stage]
The values in the pairs of the Prolog CMR format can be a term (i.e., a string or a number)
or a list with the PrologCMR format. Namely it allows for a tree-structured data. For example,
we can merge the properties of hormone receptors in the list above into a property-value pair,
like this: hermone receptor status:[her2:HER2, er:ER, pr:PR].
This general format of patient data is flexible enough to represent the data from different
formats of CMRs, because we can design a CMR-specific interface to obtain the corresponding
data via different data servers, which can be a SPARQL endpoint, internal data storage server,
or a database server. Then, we can convert the patient data into the PrologCMR format. We
introduce the general predicate getItem(PatientData, Property, Value) to get the value of the
property from the patient data.
Several receptor status of breast cancer cells have been considered to be very important
for the classification of breast cancer. Those important receptors are estrogen receptor (ER),
progesterone receptor (PR), and Human Epidermal growth factor Receptor 2(HER2). These
receptor status can be straight forward formalized as follows:
6 identifier from clinicaltrial.gov
er_positive(PatientData):- getItem(PatientData, er, ER), ER = ’positive’.
er_negative(PatientData):- getItem(PatientData, er, ER), ER = ’negative’.
Similarly we can define the predicates for PR and HER2.
More complex criteria where real domain knowledge is involved for instance the triple-negative
breast cancer status which means that a patient of breast cancer is triple negative if she is ER
negative, PR negative, and HER2 negative. This can be formalised as follows:
triple_negative(PatientData):-
er_negative(PatientData),
pr_negative(PatientData),
her2_negative(PatientData).
The menopausal status of a female patient is simply considered as a value of a property in
the patient data. Actually in medical science, menopausal status is defined in terms of menstrual
periods.
last_time(Patient, menstrual_period, LastMenstrucalPeriod):-
hasPatientData(Patient,PatientData),
postmenopausal(PatientData),
today(Today),
at_least_earlier(LastMenstrucalPeriod, Today, 1, year).
The definitions of those temporal predicates (e.g. at least earlier) belong to the common
knowledge level.
4.3 Formalization of Common Knowledge
Temporal Reasoning The rules for formalizing temporal reasoning and others are not domain-
specific, because that kind of knowledge can be used in different applications. Thus, they are
designed to be separated libraries, which are different from the domain specific libraries.
For reasoning with breast cancer knowledge, we may need various temporal operators(i.e.,
predicates), like those “before”, “after”, “until”, “today”, “no less than 6 months before”, etc.
Such general temporal operators are well known from the AI literature [4].
To summerise the general framework has three knowledge types: (1) clinical trial specific
knowledge, (2) domain-specific knowledge, and (3) common knowledge. The clinical trial specific
knowledge specified the eligibility criteria in terms of predicates defined in the domain-specific
level if they are domain dependent and in the common knowledge level if they are domain
independent but common knowledge. The levels (2) and (3) are the reusable parts for the for-
malisation of eligibility criteria whereas (1) use those re-usable parts in the formalisation of a
specific eligibility criteria.
5 Implementation and Feasibility Experiment
5.1 Implementation
SWI-Prolog provides a powerful Semantic Web library, by which we can achieve semantic interop-
erability in the rule-based formulation of eligibility criteria efficiently and effectively. SWI-Prolog
handles the semantic web RDF model and OWL data naturally. RDF and OWL provide stable
models for knowledge representation with nice support for semantic interoperability.
The rule-based formulation of eligibility criteria of clinical trials is developed with the support
of the following two semantic web libraries in SWI-Prolog:
Web-server and client library. This is the core semantic web package of SWI-Prolog. It pro-
vides an HTTP server and client, session handling, authorization, logging, etc, and libraries
for generating HTML pages and JSON. Based on this library, we developed the interface with
SPARQL endpoints to obtain semantic data for the rule-based formulation of eligibility criteria.
(e.g. patient data and medical ontologies)
For example, the following rule in Prolog is designed to obtain the patient data for a SPARQL
endpoint, which is located at the localhost with the port ’8183’:
getPatientData(PatientID, PatientData):-
get_sparql_query(patientdata, Query, PatientID),
findall(Row, (sparql_query(Query, Row,[host(’localhost’), port(8183),
path(’/sparql/’)])), Answers),
sparql_answer_to_list(patientdata(PatientID), Answers, PatientData).
Namely: given a patienID, the predicate ’getPatientData’ would return the patient data from
the corresponding SPARQL endpoint. We use the predicate get sparql query(patient, Query,
PatientID) to get a system specific SPARQL query for the given patient ID. We use the built-
in predicate sparql query to obtain the result Answers from the SPARQL endpoint. We design
a predicate sparql answer to list to convert the answers from the SPARQL endpoint into the
internal representation of the patient data (i.e., a Prolog list), so that the patient data can
be processed further by the predicate getItem, as we have discussed in the section about the
formalization of domain specific knowledge.
RDF storage and query library. SWI-Prolog provides powerful support for the storage and
manipulation of semantic data, like loading and saving RDF data and querying them. This
RDF library loads and saves XML/RDF and Turtle. It also provides simple RDFS and OWL
support which is sufficient for the temporary internal storage of semantic data in the rule-based
formulation of eligibility criteria.
5.2 Feasibility
SemanticCT7 is a semantically enabled system for clinical trials. The goals of SemanticCT are
not only to achieve interoperability by semantic integration of heterogeneous data in clinical
trials, but also to facilitate automatic reasoning and data processing services for decision support
systems in various settings of clinical trials.
SemanticCT is built on the top of the LarKC (Large Knowledge Collider) platform8, a plat-
form for scalable semantic data processing. We have implemented the rule-based formulization
of eligibility criteria as a component of SemanticCT for the service of automatic identification of
eligible patients for clinical trials.
Experiment design: An ideal experimental scenario would look as follows: (i) take realistic
corpus of patient records for included and excluded patients for a given set of trials; (ii) formalise
the inclusion and exclusion conditions for these trials; (iii) execute these formalised criteria on the
data of included and excluded patients; and (iv) compare precision and recall of the automatically
selected set of patients against the actual selections as given in the corpus.
Available data: A corpus of current and past clinical trials is readily available 9 but given
the lack of a realistic collection of patient data for such trials, we limit ourselves in this paper
to a feasibility study that shows how two important tasks can in principle be supported by the
formalisation and implementation that we discussed above. Our experiments concern a patient
recruitment task (= finding patients that qualify for a given trial), and a trial feasibility task (=
7 http://wasp.cs.vu.nl/sct
8 http://www.larkc.eu
9 e.g. clinicaltrial.gov
checking if a set of inclusion and exclusion criteria for a newly designed trial results in a sufficient
number of recruitable patients).
For a small corpus of clinical trials in our experiments, we have picked up 10 clinicial trials
of breast cancer out of the 4665 NCT clinical trials (1,200,565 triples) and we formalized the
eligibility criteria of those selected trials (the trial ID numbers are listed in the tables that follow).
For patient data, we generated a set of 10,000 plausible patient files created by our Knowledge-
based Patient Data Generator10. This Knowledge-Based Patient Data Generator uses clinical and
epidemiological background knowledge to generate a patient population that is both medically
plausible, and that has a realistic statistical distribution.
Experiment 1: Patient Recruitment: Some eligibility criteria cannot be checked automatically
over the patient data, because they need additional input from patients, like the criteria ’Patients
must be mentally competent to understand and give informed consent for the protocol’. Some
eligibility criteria have not yet been checked, because their corresponding data have not yet been
available in the existing patient data format, like the criteria ’Must have regular menstrual cycles
(21-35 days)’.
Table 1 reports on a (simulated) patient recruitment scenario, and summarises how many
criteria have been checked in the test. The table shows that we can check maximally 83.33% of
the criteria, and minimally 34.48% of the criteria, based on the given patient data.
Clinical Total Checked Total Total Checked Checked NYC NYC Checked Criteria
Trial ID Criteria Criteria IC EC IC EC IC EC Rate(%)
NCT00001250 22 15 11 11 7 8 4 3 68.18
NCT00001385 18 15 9 9 7 8 2 1 83.33
NCT00002720 10 7 9 1 7 0 2 1 70.00
NCT00002762 15 7 10 5 5 2 5 3 46.67
NCT00002934 26 10 20 6 9 1 11 5 38.46
NCT00003329 6 3 5 1 3 0 2 1 50.00
NCT00003654 18 11 1 0 8 9 2 1 6 61.11
NCT00005023 29 10 27 2 9 1 18 1 34.48
NCT00005079 18 11 10 8 7 4 3 4 61.11
NCT00005587 16 10 12 4 10 0 2 4 62.50
Table 1. Checked Eligibility Criteria. IC:Inclusion Criteria, EC: Exclusion Criteria, NYC: Not Yet
Checked Items
Experiment 2: Trial Feasibility In this feasibility experiment, we use our system to automat-
ically determine if a given target number of patients can be recruited for a trial: T200 stands
for finding 200 candidate patients, and T500 stands for finding 500 candidate patients, from the
total 10,000 patients. Table 2 shows the results of trial feasibility with different targets. For the
lower target (e.g., T200), we can always find the targeted numbers of the candidate patients who
meet the checked criteria. For the higher target (e.g., T750), we cannot find enough candidate
patients for four trials. Furthermore, a lower percentage of checked items does not necessary lead
to higher recruitment rate. For example, Trial ’NCT00002762’ (with checked item rate 46.67)
can find only 32.13 percent of the target. That means that some of checked criteria in this trial
have low feasibility, and the limited number of the patient data also lead to the difficulties.
These experiments show that conditions of realistic trials can be formalised and implemented
in such a way that, at least on our artificially generated but medically and statistically plausible
patient data, both patient recruitment and trial feasibility can be supported.
10 http://wasp.cs.vu.nl/apdg
Clinical T200 T200 T300 T300 T500 T500 T750 T750
TrialID Founded Rate(%) Founded Rate(%) Founded Rate(%) Founded Rate (%)
NCT00001250 200 100 300 100 500 100.00 750 100
NCT00001385 200 100 300 100 500 100 750 100
NCT00002720 200 100 300 100 397 79.40 397 52.93
NCT00002762 200 100 241 80.33 241 48.20 241 32.13
NCT00002934 200 100 300 100 500 100 750 100
NCT00003329 200 100 300 100 500 100 750 100
NCT00003654 200 100 300 100 500 100 750 100
NCT00005023 200 100 300 100 500 100 501 66.80
NCT00005079 200 100 281 93.67 281 56.20 281 37.47
NCT00005587 200 100 300 100 500 100 750 100
Table 2. Trial Feasibility
6 Related Work, Discussion and Conclusion
6.1 Related Work
An extensive survey of formal representations of eligibility criteria appears in [5]. Below we
discuss a subset of papers that can be directly compared to our own work.
In [6] the authors translate each free-text eligibility criterion into a machine executable state-
ment using a derivation of the Arden Syntax. Clinical trial protocols were then structured as
collections of these eligibility criteria using XML. In our work, we use a more expressive rule-based
language and then structured the eligibility criteria as RDF.
[7] presents a method entirely based on standard semantic web technologies and tools, that
allows the automatic recruitment of a patient to available clinical trials. They use a domain
specific ontology to represent data from patients’ health records and use SWRL to verify the
eligibility of patients to clinical trials. Although we propose an even more expressive language
for modelling the eligibility criteria this is in the same spirit as our approach. Furthermore, we
proposed a general framework for specifying the eligibility criteria in three types of knowledge
to facilitate reuse.
The purpose of [8] is to develop algorithms that automatically identify qualified patients for
breast cancer clinical trials from free-text medical reports. Similarly, TrialX [9] is a consumer-
centric tool that matches patients to clinical trials by extracting their PHR information and
linking it to the most relevant clinical trials using semantic web technologies. As a further exam-
ple, [10] annotates free text criteria with ERGO annotations. The matching algorithms in these
works combine semantic and NLP techniques. In our approach we first do the modeling of the
eligibility criteria based on the three different levels of knowledge in a rule-based approach and
then we do the matching against the patient data automatically.
The empirical analysis in [11] shows that the vast majority (85%) of trial criteria is of ”signif-
icant semantic complexity”. This justifis our choice for an expressive rule-based formalism. The
paper also observes that temporal data play a role in 40% of all criteria, justifying our choice for
a separate layer for this in our formalisation.
Our rules are currently limited to boolean yes/no judgements on criteria. The work in [12]
also considers a probabilistic approach. This would be an interesting future extension of our
formalism.
6.2 Discussion and Conclusion
For clinical trials, identifying eligible patients are mostly manually. Thus, it often results in low
clinical trial enrolment. The formulation of eligibility criteria provides the possibility for faster
identification of patients for clinical trials. Based on the rule-based formulation of eligibility
criteria, we can achieve an efficient way for automatic identification of eligible patients whenever
possible.
With the support of the Semantic Web library in the Prolog-based formalism, we can achieve
the semantic interoperability among EHR and clinical trial systems, because the relevant can
be exploited to allow more efficient patient enrolment in clinical trials. Semantic interoperability
between EHR and CT systems enables us to provide solutions for patient recruitment that help
avoid double data entry: establishing a single source for each data item, automatic storing of
clinical trial eligibility criteria into the EHR and using the EHR data for automatic Electronic
Data Capture (EDC).
However, automatic patient recruitment for clinical trials would not be considered as a simple
system of automatic checking with the criteria of patient data. In many application scenarios
of patient recruitment, it should be considered to be one with a decision making system, which
involves complex procedure and comprehensive processing over various data and workflows. Fur-
thermore, it would be also beneficial if the formalism can accommodate and integrate with the
clinical guidelines for specific diseases [13]. That requires that rule-based formulation of eligibility
criteria can be extended with more powerful workflow processing. We will leave the integration of
rule-based formulation of eligibility criteria with integrated guidelines as one of the future work.
Acknowledgment This work is partially supported by the European Commission under the
7th framework programme EURECA Project.
References
[1] Bucur, A., ten Teije, A., van Harmelen, F., Tagni, G., Kondylakis, H., van Leeuwen, J., Schepper,
K.D., Huang, Z.: Formalization of eligibility conditions of ct and a patient recruitment method,
deliverable d6.1. Technical report, EURECA Project (2012)
[2] Huang, Z., ten Teije, A., van Harmelen, F.: SemanticCT: A semantically enabled system for clinical
trials. Technical report, under preparation (2012)
[3] Wielemaker, J., Schrijvers, T., Triska, M., Lager, T.: Swi-prolog. Journal of Theory and Practice
of Logic Programming (1-2) (2012) 67–96
[4] Allen, J.F.: Maintaining knowledge about temporal intervals. CACM 26(11) (1983) 832–843
[5] Domschke, S., Domschke, W.: Antirheumatic drug-induced damage of the gastroduodenal mucosa:
approach to prevention. Internist (Berl) 27(10) (Oct 1986) 630–636
[6] Ohno-Machado, L., Wang, S.J., Mar, P., Boxwala, A.A.: Decision support for clinical trial eligibility
determination in breast cancer. Proc AMIA Symp (1999) 340–344
[7] Besana, P., Cuggia, M., Zekri, O., Bourde, A., Burgun, A.: Using semantic web technologies for
clinical trial recruitment. In: International Semantic Web Conference. (2010) 34–49
[8] Zhang, J., Gu, Y., Liu, W., Hu, W., Zhao, T., Mu, X., Marx, J., Frost, F., Tjoe, J.: Automatic
patient search for breast cancer clinical trials using free-text medical reports. In: ACM International
Health Informatics Symposium, IHI 2010, ACM (2010) 405–409
[9] Patel, C., Gomadam, K., Khan, S., Garg, V.: Trialx: Using semantic technologies to match patients
to relevant clinical trials based on their personal health records. J. Web Sem. 8(4) (2010) 342–347
[10] Tu, S.W., Peleg, M., Carini, S., Bobak, M., Ross, J., Rubin, D., Sim, I.: A practical method for
transforming free-text eligibility criteria into computable criteria. J Biomed Inform 44(2) (Apr
2011) 239–250
[11] Ross, J., Tu, S., Carini, S., Sim, I.: Analysis of eligibility criteria complexity in clinical trials. AMIA
Summits Transl Sci Proc 2010 (2010) 46–50
[12] Tu, S.W., Kemper, C.A., Lane, N.M., Carlson, R.W., Musen, M.A.: A methodology for determining
patients’ eligibility for clinical trials. Methods Inf Med 32(4) (Aug 1993) 317–325
[13] de Clercq, P., Blom, J., Korsten, H., Hasman, A.: Approaches for creating computer-interpretable
guidelines that facilitate decision support. Artif Intell Med (1) (May 2004) 1–27
